QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$16.89
0.54 (3.30%)
▲
5d:
+3.24%
30d:
+87.04%
90d:
-28.97%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 08, 2026
Smart Money Accumulation
QURE is down 7.5% this week, but smart money is accumulating calls. Top strike: $20 2026-05-15 with 249 OI. Call ratio: 60% View Scanner →
Strength: 4.7/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: QURE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: QURE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $16.89, which is considered fair relative to its 30-day fair value range of $12.29 to $19.80.
Technical Outlook: Technically, QURE is in a strong downtrend. Immediate support is located at $14.17, while resistance sits at $17.72. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: QURE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.87 (+124.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QURE is in a strong downtrend. Immediate support is located at $14.17, while resistance sits at $17.72. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: QURE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $37.87 (+124.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$12.29 -
$19.80
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 124.2% below Wall St target ($37.87)
Fair Price Analysis
30-Day Fair Range
$12.29 -
$19.80
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$14.17
Resistance Level
$17.72
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.25
Wall Street Target
$37.87
(+124.2%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: April 02, 2026 9:38 AM ET
Data refreshes hourly during market hours. Next update: 10:38 AM
Data refreshes hourly during market hours. Next update: 10:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$43 | 65 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
